Advertisement

Topics

ERSPC (European Randomized Study of Screening for Prostate Cancer) Company Profile

16:36 EDT 19th September 2017 | BioPortfolio


News Articles [11277 Associated News Articles listed on BioPortfolio]

Prostate cancer screening reduces cancer deaths finds new analysis

There has been much debate regarding the utility of prostate cancer screening in reducing the rates of deaths due to this cancer among men. While the ERSPC (European Randomized Study of Screening for ...

PSA Screening Decreases Risk Of Dying From Prostate Cancer, Says New Studies

Dr David Samadi, chairman of urology and chief of robotic surgery at Lenox Hill Hospital, shares his expert commentary on a recent study finding PSA screening for prostate cancer reduces deaths from p...

PSA Screening Does Reduce Deaths, New Analysis Shows

A new analysis of data from the PLCO and the ERSPC screening trials found that both studies show that PSA screening reduces death from prostate cancer. Medscape Medical News

Study finds screening linked to reduced risk for prostate cancer death

DENVER, Sept. 5, 2017 /PRNewswire/ -- A new analysis of two clinical trials in Europe and the United States provides evidence that prostate-specific antigen (PSA) screening reduces prostate cance...

New Analysis Confirms Suspected Bias of Large U.S. Prostate Screening Study

A new paper appearing in Annals of Internal Medicine used simulation modeling to try to correct for a known bias in a notable U.S. trial of prostate cancer screening, called PLCO. That study along wi...

PSA screening significantly reduces the risk for death from prostate cancer

(American College of Physicians) After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces ...

Reconciling the Two Large Prostate Cancer Screening Trials

Researchers propose that the negative U.S. randomized trial actually supports screening — but that shouldn't change the debate about the merits of screening.

PSA screening significantly reduces the risk of death from prostate cancer

After differences in implementation and settings were accounted for, two important prostate cancer screening trials provide compatible evidence that screening reduces prostate cancer mortality. These...

Drugs and Medications [843 Associated Drugs and Medications listed on BioPortfolio]

Avodart [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Preferred Pharmaceuticals, Inc]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Avodart [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use AVODART safely and effectively. See full prescribing information for AVODART. AVODART (dutasteride) Soft Gelatin CapsulesInitial U.S....

Fareston [GTx, Inc.]

These highlights do not include all the information needed to use FARESTON® safely and effectively. See full prescribing information for FARESTON®.FARESTON® (toremifene citrate) 60 mg Tablets oral ...

Jalyn [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use JALYN safely and effectively. See full prescribing information for JALYN.JALYN (dutasteride and tamsulosin hydrochloride) CapsulesInit...

PubMed Articles [19022 Associated PubMed Articles listed on BioPortfolio]

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian Cancer Screening Tr...

Additional benefit of using a risk based selection for prostate biopsy: an analysis of biopsy complications in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

To investigate biopsy complications and hospital admissions that could be reduced by the use of ERSPC risk calculators (RC).

Editorial Comment to Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.

Prevention of Prostate Cancer Morbidity and Mortality: Primary Prevention and Early Detection.

More than any other cancer, prostate cancer screening with the prostate-specific antigen (PSA) tests increases the risk a man will have to face a diagnosis of prostate cancer. The best evidence from s...

A Survey of the Knowledge of African-American Women About Prostate Cancer Screening.

Prostate cancer is the second most common cancer diagnosed in men. Its incident and mortality rates are generally higher in populations of African descent. The scientific community recommends that men...

Clinical Trials [13629 Associated Clinical Trials listed on BioPortfolio]

Facilitating Shared Decisionmaking About Prostate Cancer Screening

Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.

Screening for Cancer of the Prostate, Lung, Colon, Rectum, or Ovaries in Older Patients

RATIONALE: Screening for cancer may enable doctors to discover and treat the disease earlier. PURPOSE: Randomized trial to determine if screening methods used to diagnose cancer of the ...

Addressing Prostate Cancer Information Disparities With eHealth Technology

his is a multicenter study that involves research on screening for prostate cancer. This study pilot tests a culturally appropriate decision aid (DA) for African American (AA) men that wil...

Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program

There is controversy concerning the preferred treatment for men with localized prostate cancer with regard to the relative effectiveness of different treatments in controlling the cancer a...

The BARCODE 1 Study

BARCODE 1 is a screening study designed to investigate the role of genetic profiling for targeting population prostate cancer screening. This study forms a pilot of 300 men, with the view ...

Companies [2876 Associated Companies listed on BioPortfolio]

ERSPC (European Randomized Study of Screening for Prostate Cancer)

European Randomized Study of Screening for Prostate Cancer (ERSPC)

Prostate Cancer Education Council

Prostate cancer remains the second-leading cause of cancer death in American men. More than 220,000 men will be diagnosed with prostate cancer this year and it is expected that 27,000 men will die fro...

Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s largest philanthropic source of support for accelerating the world’s most promising research for discovering better t...

The Prostate Cancer Foundation

The Prostate Cancer Foundation is the world’s largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for pro...

More Information about "ERSPC (European Randomized Study of Screening for Prostate Cancer)" on BioPortfolio

We have published hundreds of ERSPC (European Randomized Study of Screening for Prostate Cancer) news stories on BioPortfolio along with dozens of ERSPC (European Randomized Study of Screening for Prostate Cancer) Clinical Trials and PubMed Articles about ERSPC (European Randomized Study of Screening for Prostate Cancer) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERSPC (European Randomized Study of Screening for Prostate Cancer) Companies in our database. You can also find out about relevant ERSPC (European Randomized Study of Screening for Prostate Cancer) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record